CLINICAL TRIALS PROFILE FOR PROAIR HFA
✉ Email this page to a colleague
All Clinical Trials for Proair Hfa
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00530062 ↗ | Comparison of Single-Dose of Albuterol Breath Activated Inhaler Versus Albuterol Metered Dose Inhaler in Asthmatics | Completed | Teva Branded Pharmaceutical Products R&D, Inc. | Phase 4 | 2007-01-01 | This is a research study designed to compare the single-dose effectiveness of albuterol-HFA-BAI (breath activated inhaler) and albuterol-HFA-MDI (metered dose inhaler) in asthmatics with poor inhaler coordinating abilities. Patients must be 7 to 70 years of age to participate in this study. |
| NCT00530062 ↗ | Comparison of Single-Dose of Albuterol Breath Activated Inhaler Versus Albuterol Metered Dose Inhaler in Asthmatics | Completed | Teva Branded Pharmaceutical Products, R&D Inc. | Phase 4 | 2007-01-01 | This is a research study designed to compare the single-dose effectiveness of albuterol-HFA-BAI (breath activated inhaler) and albuterol-HFA-MDI (metered dose inhaler) in asthmatics with poor inhaler coordinating abilities. Patients must be 7 to 70 years of age to participate in this study. |
| NCT00588406 ↗ | Study of Budesonide as an Addition to Standard Therapy in Adult Asthmatics in the Emergency Room. | Completed | AstraZeneca | Phase 3 | 2007-09-01 | To determine whether adding nebulized inhaled steroids to the standard care of acutely ill ED patients with refractory acute asthma helps improve forced expiratory volume at one second (FEV1) and decrease the need for hospitalization. |
| NCT00588406 ↗ | Study of Budesonide as an Addition to Standard Therapy in Adult Asthmatics in the Emergency Room. | Completed | Jacobi Medical Center | Phase 3 | 2007-09-01 | To determine whether adding nebulized inhaled steroids to the standard care of acutely ill ED patients with refractory acute asthma helps improve forced expiratory volume at one second (FEV1) and decrease the need for hospitalization. |
| NCT00588406 ↗ | Study of Budesonide as an Addition to Standard Therapy in Adult Asthmatics in the Emergency Room. | Completed | Nassau University Medical Center | Phase 3 | 2007-09-01 | To determine whether adding nebulized inhaled steroids to the standard care of acutely ill ED patients with refractory acute asthma helps improve forced expiratory volume at one second (FEV1) and decrease the need for hospitalization. |
| NCT00588406 ↗ | Study of Budesonide as an Addition to Standard Therapy in Adult Asthmatics in the Emergency Room. | Completed | Northwell Health | Phase 3 | 2007-09-01 | To determine whether adding nebulized inhaled steroids to the standard care of acutely ill ED patients with refractory acute asthma helps improve forced expiratory volume at one second (FEV1) and decrease the need for hospitalization. |
| NCT01058863 ↗ | A Dose-ranging Study to Evaluate Albuterol and Hydrofluoroalkane in Subjects Ages 12 and Older With Persistent Asthma | Completed | Teva Branded Pharmaceutical Products R&D, Inc. | Phase 2 | 2010-02-01 | This study is examining how well a dry powder inhaler (DPI) of albuterol medication works to help adult and adolescent subjects 12 years of age and older with persistent asthma to improve lung function. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Proair Hfa
Condition Name
Clinical Trial Locations for Proair Hfa
Trials by Country
Clinical Trial Progress for Proair Hfa
Clinical Trial Phase
Clinical Trial Sponsors for Proair Hfa
Sponsor Name
